Negative Equity

Showing 2000 articles
Business

Arcellx Stock: A Tale of Two Valuations Amid Biotech Volatility

Arcellx (ACLX) shares are caught in a tug-of-war between conflicting valuation signals. While a sky-high price-to-book ratio suggests the stock is richly valued, a discounted cash flow model implies massive upside potential. We examine the data behind the biotech's recent price swings and what investors are really betting on.

Business

Three Asian Penny Stocks Defying Market Headwinds in 2026

Amidst a backdrop of stable rates and cautious optimism, a handful of low-priced Asian equities are drawing investor scrutiny for their resilience and strategic positioning. We analyze three such companies navigating property downturns, infrastructure demand, and consumer shifts.

Business

Zegna Charts Steady Course Amid Leadership Shift and China Volatility, Fueled by DTC Momentum

The Ermenegildo Zegna Group reported a resilient 2025, with full-year revenues reaching €1.92 billion. A strong fourth-quarter acceleration, driven by a 10% surge in direct-to-consumer sales, underscores the luxury group's strategic pivot away from wholesale. While the Americas and EMEA regions showed robust growth, Greater China remains a volatile market as the company navigates a planned leadership transition and industry headwinds.

Business

Three Global Penny Stocks Under $500M: Hidden Gems in a Shifting Market?

With large-cap stocks dominating in a climate of steady rates and wavering consumer sentiment, some investors are turning their gaze to smaller, often overlooked companies. We examine three penny stocks from Asia, each with a market cap below US$500 million, to assess their financial resilience and growth potential in the current environment.